This company engages in the development and manufacturing of pharmaceutical products, with no current active involvement in rare diseases or orphan drug designations.
0
Orphan Designations
8
FDA Approvals
Latest: VANCOMYCIN HYDROCHLORIDE (2018)
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
Mylan Institutional LLC is a company with 0 orphan drug designations across 0 rare diseases, including 8 FDA-approved therapies.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.